[KSCI] Korea Science Citation Index Service

http://dx.doi.org/10.7314/APJCP.2014.15.3.1085

Matrix Metalloproteinases and Cancer - Roles in Threat and Therapy

Yadav, Lalita (Department of Oral and Maxillofacial Pathology, Kalka Dental College)
Puri, Naveen (Department of Oral and Maxillofacial Pathology, Kalka Dental College)
Rastogi, Varun (Department of Oral and Maxillofacial Pathology, Kalka Dental College)
Satpute, Pranali (Department of Oral and Maxillofacial Pathology, Goverment Dental College)
Ahmad, Riyaz (GMC)
Kaur, Geetpriya (Department of Oral and Maxillofacial Pathology, Kalka Dental College)

Publication Information

Asian Pacific Journal of Cancer Prevention / v.15, no.3, 2014 , pp. 1085-1091 More about this Journal

Abstract

Matrix metalloproteinases (MMPs) are a family of zinc dependent extracellular matrix (ECM) remodelling endopeptidases having the ability to degrade almost all components of extracellular matrix and implicated in various physiological as well as pathological processes. Carcinogenesis is a multistage process in which alteration of the microenvironment is required for conversion of normal tissue to a tumour. Extracellular matrix remodelling proteinases such as MMPs are principal mediators of alterations observed in the microenvironment during carcinogenesis and according to recent concepts not only have roles in invasion or late stages of cancer but also in regulating initial steps of carcinogenesis in a favourable or unfavourable manner. Establishment of relationships between MMP overproduction and cancer progression has stimulated the development of inhibitors that block proteolytic activity of these enzymes. In this review we discuss the MMP general structure, classification, regulation roles in relation to hallmarks of cancer and as targets for therapeutic intervention.

Keywords

MMPs; MMPI; TIMP; cancer; endopeptidases; microenvironment;

Citations & Related Records

Times Cited By KSCI : 1 (Citation Analysis)

Reference
Cited By KSCI

1	Brew K, Dinakarpandian D, Nagase H (2000).Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochem Biophys Acta, 1477, 267-83.
2	Cao Z G, Li C Z (2006). A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances oral squamous cell carcinoma susceptibility in a Chinese population. Oral Oncol, 42, 32-8. DOI
3	Chambers A F, Groom A C, Macdonald I C (2002). Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer, 2, 563-72. DOI ScienceOn
4	Chambers A F, Matrisian L M (1997). Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst, 89, 1260-70. DOI ScienceOn
5	Overall C M (2002). Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinases and new 'intracellular substrate binding domains, modules and exosites. Mol Biotechnol Chem, 383, 1059-66.
6	Nagase H, Visse R, Murphy G (2006). Structure and function of matrix metalloproteinases and TIMPs. Cardiovascular Res, 69, 562-73. DOI ScienceOn
7	Nelson A R, Fingleton B, Rotherberg M L, et al (2000). Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol, 18, 1135-49.
8	Noe V et al (2001). Release of an invasion promoter E-cadherin fragment by matrilysins and stromilysin-1. J Cell Sci, 114, 111-8.
9	Overall C M, Lopez-otin C(2002). Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer, 2, 657-72. DOI ScienceOn
10	Pendas A M, Balbin M, Llano E, Jimenez M G, Lopez-otin C (1997). Structural analysis and promoter characterization of the human collagenases-3 gene (MMP-13). Genomics, 40, 222-33. DOI ScienceOn
11	Uria J A, Ferrando A A, Velasco G, Freije J M P, Lopez-otin C (1994). Structure and expression in breast tumours of human TIMP-3, a new member of the metalloproteinase family. Cancer Res, 54, 2091-94.
12	Lockhart A C, Braun R D, Yu D, et al (2003). Reduction of wound angiogenesis in patients treated with BMS-275291, a broad spectrum matrix metalloproteinase inhibitor. Clin Cancer Res, 9, 586-93.
13	Lopez-otin C, Overall C M (2002). Protease degradomics: a new challenge for proteomics. Nat Rev Mol Cell Biol, 3, 509-19. DOI
14	Manes S, Mira E, Barbacid MM, Cipres A, et al (1997). Identification of insulin -like growth binding protein-1 as a potential physiological substrate for human stromelysins-3. J Biol Chem, 272, 25706-12. DOI ScienceOn
15	Lijnen H R (2001). Plasmin and matrix metalloproteinases in vascular remodelling. Thomb Haemost, 86, 324-33.
16	Lokeshwar B L, Escatel E, Zhu B (2001). Cytotoxic activity and inhibition of tumour cell invasion by derivatives of a chemically modified tetracycline CMT-3(COL-3). Curr Med Chem, 8, 271-9. DOI
17	Maretzky T, Reiss K, Ludwig A, et al (2005). ADAM-10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion , migration and beta- catenin translocation. Proc Natl Acad Sci USA, 102, 9182-87. DOI
18	McCawley L J, Matrisian L M (2001). Matrix metalloproteinases: they are not just for matrix anymore! Curr. Opin. Cell Biol,13, 534-40. DOI ScienceOn
19	Mitsiades N, Yu W H, Poulaki V, Tsokos M, Stamenkovic I (2001). Matrix metalloproteinase-7 mediated cleavage of Fas ligand protects tumour cells from chemotherapeutic drug toxicity. Cancer Res, 61, 577-81.
20	Egeblad M ,Werb Z (2002). New function for the matrix metalloproteinases in cancer progression. Nature reviews, 2, 161-74.
21	Falardeau P, Champagne P, Poyet P, Hariton C, Dupont E (2001). Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical trials. Semin Oncol, 28, 620-5. DOI
22	Birchmeier C, Birchmeier W, Brand- saberi B (1996). Epithelialmesenchymal transition in cancer progression. ActaAnat, 156, 217-26.
23	Agrez M, Chen A, Cone R I, Pytela R, Sheppard D (1994). The ${\alpha}5{\beta}6$ integrin promotes proliferation of colon carcinoma cells through a unique region of the b6 cytoplasmic domain. J Cell Biol, 127, 547-56. DOI
24	Basbaum C B, Werb Z (1996). Focalized proteolysis: spatial and temporal regulation of extracellular matrix at the cell surface. Current Opinions in Cell Biology, 8, 731-38. DOI ScienceOn
25	Benbow U, Brinckerhoff C E (1997). The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol, 15, 519-26. DOI ScienceOn
26	Sekhon BS (2010). Matrix metalloproteinases-an overview. Res Reports Biol, 1, 20.
27	Peschon JJ, Slack JL, Reddy P, et al (1998). An essential role for ectodomain shedding in mammalian development. Science, 282, 1281-84. DOI ScienceOn
28	Rundhaung J E. Matrix Metalloproteinases, angiogenesis and cancer (2003). Clin Cancer Res, 9, 551-54.
29	Sapadin A N, Fleischmajer R (2006). Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol, 54, 258-65. DOI ScienceOn
30	Velasco G, Pendas A M, Fueyo A ,et al (1999). Cloning and characterization of human MMP-23,a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members. J BiolChem, 274, 4570-76.
31	Vihinen P, Kahari V M (2002). Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J cancer, 99, 157-66. DOI ScienceOn
32	Visse R, Nagase H (2003). Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, Function and Biochemistry. Circulation Research, 92,827-39. DOI ScienceOn
33	Waldhauer I, Goehlsdorf D, Gieseke F, et al (2008). Tumour associated MICA is shed by ADAM proteases. Cancer Res, 68, 6368-76. DOI ScienceOn
34	Westermarck J, Kahari V M (1999). Regulation of matrix metalloproteinase expression in tumour invasion. FASEB J, 13, 781-92.
35	Williamson R A, Marston F A, Angal S, et al (1990). Disulphide bond assignment in human tissue inhibitor of metalloproteinases(TIMP). Biochem J, 268, 267-74.
36	Jemal A, Tiwari RC, Murray T, et al (2004). Cancer statistics. CA Cancer J Clin, 54, 9-29.
37	Murray G I, Duncan M E, O'Neil P, Melvin W T, Fothergill J E (1996). Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med, 2, 461-2. DOI
38	Kim J, Yu W, Kovalski K, Ossowski L (1998). Requirment of specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR based assay. Cell, 94, 353-62. DOI ScienceOn
39	Illman S A, Lehti K, Keski-Oja J, Lohi J (2006). Epilysin(MMP-28) induces TGF B mediated epithelial to mesenchymal transition in lung carcinoma cells. J Cell Sci, 119, 3856-65. DOI
40	Karin M, Chang L (2001). AP-1 glucocorticoid receptor crosstalk taken to a higher level. J. Endocrinol, 169,447-51. DOI
41	Koolwijk P, Sidenius N, Peters E, et al (2001). Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12:implication for angiogenesis in fibrin matrices. Blood, 97, 3123-31. DOI
42	Kousidou O C, Mitropoulou T N, Roussidis A E, et al (2006). Genistein suppresses the invasive potential of human breast cancer cells through transcriptional regulation of metalloproteinases and their tissue inhibitors. Int J Oncol, 26, 1101-9.
43	Kuga H, Morisaki T, Nakamura K, et al (2003). Interferon gama suppreses transforming growth factor beta induced invasion of gastric carcinoma cells through cross talk of Smad pathway in a three -dimensional culture model. Oncogene, 22, 7838-47. DOI ScienceOn
44	Kumar V, Abbas A K, Fausto N (2004). Robbins and Cotran Pathologic basis of disease. 7thed; Philadelphia; Saunders; Elsevier Inc, 202-3.
45	Stamenkovic I (2003). Extracellular remodelling: the role of metalloendopeptidases. J Pathol, 200, 448-64. DOI ScienceOn
46	Zhang Y Zhang YY, Chen B, Ding YQ (2012). Metastasisassociated Factors Facilitating the Progression of Colorectal Cancer. APJCP, 13, 2436-47.
47	Stetler-Stevenson W G (1999). Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Investig, 103, 1237-41. DOI ScienceOn
48	Sheu B C, Hsu S M, Ho H N, et al (2001). A novel role of metalloproteinase in cancer-mediated immunosuppression. Cancer Res, 61, 237-42.
49	Sternlicht M D, Werb Z (2001). How matrix metalloproteinase regulate cell behaviour. Annu Rev Cell Dev Biol, 17, 463-516. DOI ScienceOn
50	Stetler-stevenson W G, Krutzsch H C, Liotta L A (1989). Tissue inhibitor of metalloproteinase (TIMP-2). J BiolChem, 264, 17374-8.
51	Steward W P, Thomas A L (2000). Marimastat: the clinical development of a matrix metalloproteinase inhibitor. Expert Opin Invesig Drugs, 9, 2913-22. DOI ScienceOn
52	Strickland D K, Ashcom J D, Williams S, et al (1990). Sequence identity between the alpha 2- macroglobulin receptor and low density lipoprotein receptor related protein suggests that this molecule is a multifunctional receptor. J BiolChem, 265, 17401-4.
53	Takeichi M (1991). Cadherin cell adhesion receptors as a morphogenetic regulator. Science, 251, 1451-55. DOI
54	Thiery J P (2002). Epithelial mesenchymal transitions in tumour progression. Nat Rev Cancer, 2, 442-54. DOI ScienceOn
55	Thomas GT, Lewis MP, Speight PM (1999). Matrixmetalloproteinases and oral cancer. Oral Oncol, 227, 33.
56	Ganea E, Trifan M, Laslo A C, Putina G, Cristescu C (2007). Matrix metalloproteinases: useful and deleterious. Biochem Soc Trans, 35, 689-91. DOI
57	Leco K J, Khokha R, Pavloff N, Hawkes S P, Edwards D R (1994). Tissue inhibitors of metalloproteinases-3 (TIMP-3) is an extracellular matrix associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem, 269, 9532-60.
58	Gialeli C, Theocharis A D, Karamanos N K (2011). Role of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J, 278, 16-27. DOI ScienceOn
59	Folgueras A R, Pendas A M, Sanchez L M, Lopez-otin C (2004). Matrix metalloproteinases in cancer: from new function to improved inhibition strategies. Int J Dev Biol, 48, 411-24. DOI
60	Gialeli C, Kletsas D, Mavroudis D, Kalofonos H P, Tzanakakis G N (2009). Targetting epidermal growth factor receptor in solid tumours: critical evaluation of the biological importance of therapeutic monoclonal antibodies. Curr Med Chem, 16, 3797-804. DOI
61	Gorelik L, Flavell R A (2001). Immune mediated eradication of tumours through the blockage of transforming growth factor-beta signalling in T-cells. Nature Med, 7, 1118-22. DOI ScienceOn
62	Greene J, Wang M, Liu Y E, et al (1996). Molecular cloning and characterisation of human tissue inhibitor of metalloproteinase 4. J BiolChem, 271, 30375-380.
63	Hanahan D, Folkman J (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86, 353-64. DOI ScienceOn
64	Hanahan D, Weinberg R A (2000). The hallmarks of cancer. Cell, 100, 57-70. DOI ScienceOn
65	Chaudhary A K, Singh M, Bharti A C, et al (2010). Genetic polymorphism of matrix metalloproteinases and their inhibitors in potentially malignant lesions of the head and neck. J Biomed Sci, 17, 10. DOI
66	Hidalgo M, Eckhardt S G (2001). Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst, 93, 178-93. DOI ScienceOn
67	Ikebe T, Shinohara M, Takeuchi H, et al (1999). Gelatinolytic activity of matrix metalloproteinase in tumour tissues correlates with invasiveness of oral cancer. Clin Exp Metastasis, 17, 315-23. DOI ScienceOn
68	Cornelius L A, et al (1998). Matrix metalloproteinases generate angiostatin: effects on neovascularisation. J Immunol, 161,6845-52.
69	Chen L C, Noelken M E, Nagase H(1993). Disruption of the cysteine-75 and zinc ion coordination is not sufficient to activate the precursor of human matrix metalloproteinase 3(stromelysin- 1). Biochemistry, 32, 10289-295. DOI
70	Choi S,Myers J N (2008). Molecular pathogenesis of oral squamous cell carcinoma: implications for Therapy. J Dent Res, 87, 14-32. DOI ScienceOn
71	Curran S,Murray G I (1999). Matrix metalloproteinases in tumour invasion and metastasis. J Pathol, 189, 300-8. DOI
72	Denhardt D T, Feng B, Edwards D R, Cocuzzi E T, Malyanker U M (1993). Tissue inhibitor of metalloproteinases(TIMP aka EPA): structure, control of expression and biological functions. PharmacolTher, 59, 329-341.
73	Eccles S A et al (1996). Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94). Cancer Res, 56, 2815-22.
74	Ferreras M, Felbor U, Lenhard T, Olsen B R, Delaisse J (2000). Generation and degradation of human endostatin protein by various proteinases. FEBS Lett, 486, 247-51. DOI
75	Wojtowicz-praga S, Low J, Marshall J, et al (1996). Phase I trial of a novel matrix metalloproteinase inhibitor batimastat(BB-94) in patients with advanced cancer. Invest New Drugs, 14, 193-202.
76	Murphy G, Reynolds J J (1993). Extracellular matrix degradation: in connective tissue and its heritable disorders. Royce P M,Steinman B, editors. New York, Wiley-Liss 287-316.

Reference
Cited By KSCI

1	Anti-invasive Activity against Cancer Cells of Phytochemicals in Red Jasmine Rice (Oryza sativa L.) / [Pintha, Komsak;Yodkeeree, Supachai;Pitchakarn, Pornsirit;Limtrakul, Pornngarm;] / Asian Pacific Journal of Cancer Prevention
2	Lack of Association Between the Matrix Metalloproteinase-2 -1306C>T Polymorphism and Breast Cancer Susceptibility: a Meta-analysis / [Yang, Lu;Li, Ning;Wang, Siyu;Kong, Yanan;Tang, Hailin;Xie, Xinhua;Xie, Xiaoming;] / Asian Pacific Journal of Cancer Prevention
3	Association of Matrix Metalloproteinase (MMP)-2 and -9 Expression with Extra-gastrointestinal Stromal Tumor Metastasis / [Wang, Chao;Ma, Hong-Xi;Jin, Mei-Shan;Zou, Ya-Bin;Teng, Yong-Liang;Tian, Zhuang;Wang, Hai-Ying;Wang, Yin-Ping;Duan, Xiu-Mei;] / Asian Pacific Journal of Cancer Prevention
4	Roles of Oxidative Stress in the Development and Progression of Breast Cancer / [Nourazarian, Ali Reza;Kangari, Parisa;Salmaninejad, Arash;] / Asian Pacific Journal of Cancer Prevention
5	The MMP-2 -735 C Allele is a Risk Factor for Susceptibility to Breast Cancer / [Yari, Kheirollah;Rahimi, Ziba;Moradi, Mohamad Taher;Rahimi, Zohreh;] / Asian Pacific Journal of Cancer Prevention
6	Suppression of Human Breast Cancer Cell Metastasis by Coptisine in Vitro / [Li, Jing;Qiu, Dong-Min;Chen, Shao-Hua;Cao, Su-Ping;Xia, Xue-Lan;] / Asian Pacific Journal of Cancer Prevention

1	Yuan‑Yuan Shen. (2012) Molecular Medicine Reports Molecular mechanism underlying the anticancer effect of simvastatin on MDA-MB-231 human breast cancer cells / 12 (1) , 623
10	Chao Wang. (2014) Asian Pacific Journal of Cancer Prevention Association of Matrix Metalloproteinase (MMP)-2 and -9 Expression with Extra-gastrointestinal Stromal Tumor Metastasis / 15 (10) , 4187
12	Ali Reza Nourazarian. (2014) Asian Pacific Journal of Cancer Prevention Roles of Oxidative Stress in the Development and Progression of Breast Cancer / 15 (12) , 4745
12	Lu Yang. (2014) Asian Pacific Journal of Cancer Prevention Lack of Association Between the Matrix Metalloproteinase-2 -1306C>T Polymorphism and Breast Cancer Susceptibility: a Meta-analysis / 15 (12) , 4823
14	Jing Li. (2014) Asian Pacific Journal of Cancer Prevention Suppression of Human Breast Cancer Cell Metastasis by Coptisine in Vitro / 15 (14) , 5747
15	Kheirollah Yari. (2014) Asian Pacific Journal of Cancer Prevention The MMP-2 -735 C Allele is a Risk Factor for Susceptibility to Breast Cancer / 15 (15) , 6199
1	Yang Sun. (2014) Oncology Reports Inhibitory effect of emodin on migration, invasion and metastasis of human breast cancer MDA-MB-231 cells in vitro and in vivo / 33 (1) , 338
1523-5866	J. M. Kros. (2014) Neuro-Oncology Circulating glioma biomarkers / (1523-5866)
5	Wei Zhang. (2015) Molecular Medicine Reports Additive effects of eukaryotic co-expression plasmid carrying GRIM-19 and LKB1 genes on breast cancer in vitro and in vivo / 12 (5) , 7665
1	Chang-Han Chen. (2015) Molecular Cancer Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer / 14 (1)
24	Hao He. (2015) Asian Pacific Journal of Cancer Prevention Steroidal Saponins from Paris polyphylla Suppress Adhesion, Migration and Invasion of Human Lung Cancer A549 Cells Via Down-Regulating MMP-2 and MMP-9 / 15 (24) , 10911
4	Alireza Lotfi. (2015) Asian Pacific Journal of Cancer Prevention Serum Levels of MMP9 and MMP2 in Patients with Oral Squamous Cell Carcinoma / 16 (4) , 1327
7	Serife Gokce Caliskan. (2015) Asian Pacific Journal of Cancer Prevention Effect of Pulsed Electromagnetic Field on MMP-9 and TIMP-1 Levels in Chondrosarcoma Cells Stimulated with IL-1β / 16 (7) , 2701
4	Nilufer Avcı. (2015) Pathology & Oncology Research Association and Prognostic Significance of the Functional −1562C/T Polymorphism in the Promoter Region of MMP-9 in Turkish Patients with Gastric Cancer / 21 (4) , 1243
10	J C Evans. (2015) Gene Therapy Cyclodextrin mediated delivery of NF-κB and SRF siRNA reduces the invasion potential of prostate cancer cells in vitro / 22 (10) , 802
3	Jie Gu. (2015) Medical Oncology Capn4 promotes non-small cell lung cancer progression via upregulation of matrix metalloproteinase 2 / 32 (3)
5	Dalel Ben Nejima. (2015) Tumor Biology Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study / 36 (5) , 3815
5	Yong-Li Jiang. (2015) Chemical Biology & Drug Design Synthesis and Evaluation of Trehalose-Based Compounds as Novel Inhibitors of Cancer Cell Migration and Invasion / 86 (5) , 1017
1	Fanling Meng. (2015) Chemical Biology & Drug Design / 87 (1) , 121
18	Peng Yang. (2016) Asian Pacific Journal of Cancer Prevention Potential Roles of Protease Inhibitors in Cancer Progression / 16 (18) , 8047
6	Xiaoxia Wang. (2016) Acta Biochimica et Biophysica Sinica Aurora-A modulates MMP-2 expression via AKT/NF-κB pathway in esophageal squamous cell carcinoma cells / 48 (6) , 520
1	Eliana Noelia Alonso. (2017) Nutrition and Cancer (Maitake) Mushroom in Breast Cancer / 69 (1) , 29
1552-695X	(2017) Integrative Cancer Therapies Molecular Mechanisms Underlying the Inhibitory Effects of Qingzaojiufei Decoction on Tumor Growth in Lewis Lung Carcinoma / (1552-695X) , 153473541769495
11	Renato Silva-Oliveira. (2016) International Journal of Molecular Sciences Tapirira guianensis Aubl. Extracts Inhibit Proliferation and Migration of Oral Cancer Cells Lines / 17 (11) , 1839
3	(2016) Oncology Letters Tauroursodeoxycholic acid reduces the invasion of MDA-MB-231 cells by modulating matrix metalloproteinases 7 and 13 / 12 (3) , 2227
3	(2016) Oncology Letters Effects of RNA silencing of matrix metalloproteinase-2 on the growth of esophageal carcinoma cells in vivo / 13 (3) , 1119
6	(2016) International Journal of Oncology Exosome-shuttling microRNA-21 promotes cell migration and invasion-targeting PDCD4 in esophageal cancer / 48 (6) , 2567
1942-0994	(2018) Oxidative Medicine and Cellular Longevity Nutrients and Oxidative Stress: Friend or Foe? / 2018 (1942-0994) , 1
12	Chou-Kit Chou. (2015) International Journal of Molecular Sciences BubR1 Acts as a Promoter in Cellular Motility of Human Oral Squamous Cancer Cells through Regulating MMP-2 and MMP-9 / 16 (12) , 15104
4	(2016) Oncology Letters MMP-14 and TGFβ-1 methylation in pituitary adenomas / 12 (4) , 3013
2314-7156	(2018) Journal of Immunology Research Mediators of Inflammation – A Potential Source of Biomarkers in Oral Squamous Cell Carcinoma / 2018 (2314-7156) , 1
1	(2018) Scientific Reports MMP8 and MMP9 gene polymorphisms were associated with breast cancer risk in a Chinese Han population / 8 (1)
4	(2018) Journal of Cellular Physiology Glabridin inhibits osteosarcoma migration and invasion via blocking the p38- and JNK-mediated CREB-AP1 complexes formation / 234 (4) , 4167
1478-6427	(2019) Natural Product Research / (1478-6427) , 1
1573-4978	(2019) Molecular Biology Reports Decreased MMP1 gene expression in acute myeloid leukaemia / (1573-4978)
10	(2018) International Journal of Molecular Sciences Molecular and Immunohistochemical Markers with Prognostic and Predictive Significance in Liver Metastases from Colorectal Carcinoma / 19 (10) , 3014
1744-8387	(2018) Expert Review of Proteomics Metalloproteinases in disease: identification of biomarkers of tissue damage through proteomics / (1744-8387) , 1
1	(2018) BMC Cancer Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triple-negative breast cancer patients / 18 (1)
5	(2018) International Journal of Molecular Sciences The Impact of Human Papilloma Viruses, Matrix Metallo-Proteinases and HIV Protease Inhibitors on the Onset and Progression of Uterine Cervix Epithelial Tumors: A Review of Preclinical and Clinical Studies / 19 (5) , 1418
5	(2019) Journal of Cellular Physiology The role of microRNAs regulating the expression of matrix metalloproteinases (MMPs) in breast cancer development, progression, and metastasis / 234 (5) , 5399
2095-0225	(2019) Frontiers of Medicine Urotensin II receptor antagonist reduces hepatic resistance and portal pressure through enhanced eNOS-dependent HSC vasodilatation in CCl4-induced cirrhotic rats / (2095-0225)